[go: up one dir, main page]

MY126253A - Capsules for inhalation - Google Patents

Capsules for inhalation

Info

Publication number
MY126253A
MY126253A MYPI20022036A MYPI20022036A MY126253A MY 126253 A MY126253 A MY 126253A MY PI20022036 A MYPI20022036 A MY PI20022036A MY PI20022036 A MYPI20022036 A MY PI20022036A MY 126253 A MY126253 A MY 126253A
Authority
MY
Malaysia
Prior art keywords
inhalation
capsules
inhalettes
whcih
contain
Prior art date
Application number
MYPI20022036A
Inventor
Dieter Dr Hochrainer
Karoline Dr Bechtold-Peters
Michael Dr Trunk
Michael Dr Walz
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY126253(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY126253A publication Critical patent/MY126253A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE INVENTION RELATES TO CAPSULES FOR INHALATION (INHALETTES) MADE FROM SPECIFIC CAPSULE MATERIALS WITH A REDUCED MOISTURE CONTENT, WHCIH CONTAIN THE ACTIVE SUBSTANCE TIOTROPIUM IN THE FORM OF POWDERED PREPARATIONS AND ARE CHARACTERISED BY INCREASED STABILITY. (FIG. 1)
MYPI20022036A 2001-06-01 2002-05-31 Capsules for inhalation MY126253A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (en) 2001-06-01 2001-06-01 Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability

Publications (1)

Publication Number Publication Date
MY126253A true MY126253A (en) 2006-09-29

Family

ID=7687020

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20022036A MY126253A (en) 2001-06-01 2002-05-31 Capsules for inhalation

Country Status (37)

Country Link
EP (2) EP1379220B1 (en)
JP (3) JP4447311B2 (en)
KR (2) KR100952321B1 (en)
CN (3) CN101829072A (en)
AR (2) AR034346A1 (en)
AT (1) ATE285752T1 (en)
AU (2) AU2002344354B2 (en)
BG (1) BG65655B1 (en)
BR (1) BR0209366A (en)
CA (1) CA2448425C (en)
CH (1) CH1379220H1 (en)
CO (1) CO5540379A2 (en)
CZ (1) CZ300284B6 (en)
DE (2) DE10126924A1 (en)
EA (1) EA005188B1 (en)
EC (2) ECSP034868A (en)
EE (1) EE05416B1 (en)
EG (1) EG24227A (en)
ES (1) ES2236590B5 (en)
HR (1) HRP20030993B1 (en)
HU (3) HU230827B1 (en)
IL (2) IL158917A0 (en)
ME (1) ME00301B (en)
MX (1) MXPA03010990A (en)
MY (1) MY126253A (en)
NO (1) NO332857B3 (en)
NZ (1) NZ530356A (en)
PE (1) PE20030071A1 (en)
PL (2) PL205714B1 (en)
PT (1) PT1379220E (en)
RS (1) RS50353B (en)
SI (1) SI1379220T1 (en)
SK (2) SK287379B6 (en)
TW (1) TWI327921B (en)
UA (1) UA75659C2 (en)
WO (1) WO2002098874A2 (en)
ZA (1) ZA200308340B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0107304A (en) 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Inhalation powder containing tiotropium
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10212264A1 (en) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
CA2483914A1 (en) * 2002-05-07 2003-11-20 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium-containing powder formulation for inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10258360A1 (en) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Chamber for accommodation of disposable capsules for powder inhalers has an inner surface with protruding elements serving as distance pieces between the capsules
DE10352277A1 (en) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
SE0303570L (en) 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
RU2369411C2 (en) * 2005-04-21 2009-10-10 Бёрингер Ингельхайм Интернациональ Гмбх Powder inhalator
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (en) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Powder inhaler
DE102006016901A1 (en) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (en) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
DE102007052871A1 (en) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Capsule for receiving pharmaceutical drug formulations
US20100327476A1 (en) * 2008-02-08 2010-12-30 Boehringer Ingelheim International Gmbh Method and device for filling capsules
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
EP3578169B1 (en) 2009-02-26 2024-06-26 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
EP2411008B1 (en) * 2009-03-27 2017-03-22 Mahmut Bilgic Complexes of tiotropium with improved properties of solubility and stability
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2011152804A2 (en) 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations
DE202011102694U1 (en) 2011-06-29 2011-12-19 Zisser Gmbh Inhaler for home users
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US20150150802A1 (en) 2012-07-05 2015-06-04 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhaler compositions comprising long acting muscarinic antagonists
DE202013000774U1 (en) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturized inhalation device for home use
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (en) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 A kind of plant hollow capsule and its capsule for sucking medicament
CN108451920A (en) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 A kind of suction mist formula capsule and preparation method thereof
CN114848605B (en) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 Gelatin capsule for inhalation of powder fog agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
ATE204750T1 (en) * 1992-06-12 2001-09-15 Teijin Ltd PHARMACEUTICAL PREPARATION FOR USE IN THE RESPIRATORY CIRCULATION
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (en) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for pharmaceutical preparations for powder inhalers
JP2000143502A (en) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk Inhalation formulation
RU2221552C2 (en) * 1998-11-13 2004-01-20 Джаго Рисерч Аг Dry inhalation powder
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
EP1072258A1 (en) * 1999-07-28 2001-01-31 Greither, Peter Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof
AU7685200A (en) * 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability

Also Published As

Publication number Publication date
BR0209366A (en) 2004-06-08
AU2008203057A1 (en) 2008-07-31
KR100921904B1 (en) 2009-10-16
CN101829072A (en) 2010-09-15
ATE285752T1 (en) 2005-01-15
PL364108A1 (en) 2004-12-13
HUP0400666A3 (en) 2009-06-29
EE200300595A (en) 2004-02-16
HRP20030993B1 (en) 2011-10-31
JP4447311B2 (en) 2010-04-07
EP1379220A2 (en) 2004-01-14
HUP1500188A2 (en) 2005-03-29
IL158917A (en) 2008-11-03
EA200301275A1 (en) 2004-06-24
HU230827B1 (en) 2018-07-30
CN1512875A (en) 2004-07-14
BG65655B1 (en) 2009-05-29
KR20090010140A (en) 2009-01-28
PT1379220E (en) 2005-03-31
JP2005500279A (en) 2005-01-06
ZA200308340B (en) 2004-05-21
NO20035265D0 (en) 2003-11-27
WO2002098874A3 (en) 2003-09-12
AU2008203057C8 (en) 2017-04-06
ECSP11004868A (en) 2011-02-28
JP2006143747A (en) 2006-06-08
TWI327921B (en) 2010-08-01
NZ530356A (en) 2005-05-27
AR084804A2 (en) 2013-06-26
RS50353B (en) 2009-11-10
CZ20033579A3 (en) 2004-05-12
PL203801B1 (en) 2009-11-30
UA75659C2 (en) 2006-05-15
EG24227A (en) 2008-11-10
PL205714B1 (en) 2010-05-31
CZ300284B6 (en) 2009-04-08
YU93503A (en) 2006-05-25
WO2002098874A2 (en) 2002-12-12
CA2448425C (en) 2010-12-21
DE10126924A1 (en) 2002-12-05
KR20040007638A (en) 2004-01-24
JP2008050364A (en) 2008-03-06
EA005188B1 (en) 2004-12-30
AU2008203057C1 (en) 2017-05-18
IL158917A0 (en) 2004-05-12
AR034346A1 (en) 2004-02-18
AU2008203057B2 (en) 2011-12-08
ME00301B (en) 2011-05-10
HUP0400666A2 (en) 2005-03-29
NO332857B3 (en) 2016-01-25
PL387118A1 (en) 2004-12-13
MEP42508A (en) 2011-02-10
BG108380A (en) 2004-11-30
NO332857B1 (en) 2013-01-21
PE20030071A1 (en) 2003-03-04
EP1508330A1 (en) 2005-02-23
ES2236590B5 (en) 2018-03-05
DE50201898D1 (en) 2005-02-03
CN101697965A (en) 2010-04-28
EE05416B1 (en) 2011-06-15
HRP20030993A2 (en) 2005-08-31
CH1379220H1 (en) 2018-10-31
CA2448425A1 (en) 2002-12-12
KR100952321B1 (en) 2010-04-09
SK16202003A3 (en) 2004-05-04
SK287379B6 (en) 2010-08-09
MXPA03010990A (en) 2004-02-27
ES2236590T3 (en) 2005-07-16
HU231082B1 (en) 2020-06-29
SI1379220T1 (en) 2005-04-30
JP4787034B2 (en) 2011-10-05
HU230058B1 (en) 2015-06-29
SK287346B6 (en) 2010-07-07
EP1379220B1 (en) 2004-12-29
NO20035265L (en) 2003-11-27
AU2002344354B2 (en) 2008-08-07
ECSP034868A (en) 2004-03-23
CO5540379A2 (en) 2005-07-29

Similar Documents

Publication Publication Date Title
MY126253A (en) Capsules for inhalation
NO20015082L (en) Powder inhalation device for combined drug
NO943463L (en) Separator for powder inhalers
NO20010535L (en) Two-part capsule for the absorption of pharmaceutical preparations for powder inhalers
IS1768B (en) Inhalant pharmaceutical composition containing insulin
NL193930B (en) Inhaler with package for powdered medicine as well as such medicine package.
WO2001049274A3 (en) Methods for pulmonary delivery of interleukin-2
MY124329A (en) Active substance concentrate with formoterol, suitable for storage.
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
NL1008021A1 (en) New formulation for inhalation.
EA200500387A1 (en) COMPOSITIONS FOR INHALATION WITH HIGH CONTENT OF MEDICINAL SUBSTANCES
DE69917658D1 (en) MICRONIZED PHARMACEUTICAL COMPOSITIONS
TW200500066A (en) New tiotropium containing powder formulation for inhalation
AU2001230533A1 (en) Powdered preparation for inhalation and powder inhalant containing the same packed
ES283765U (en) New dust inhaler contained in capsules (Machine-translation by Google Translate, not legally binding)
UY27314A1 (en) INHALATION CAPSULES